Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

9.580 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 9.580
Bid (Size) 2.500 (2)
Ask (Size) 11.48 (1)
Prev. Close 9.580
Today's Range 9.580 - 9.580
52wk Range 7.800 - 32.54
Shares Outstanding 358,808,755
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
NYSE:BHC Investor Notice: Investigation over Possible Securities Laws Violations by Bausch Health Companies Inc.
San Diego, CA -- (SBWIRE) -- 05/18/2022 -- Bausch Health Companies Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
Bausch Health's Q1 Sales, Profits Fall On Supply Chain Challenges, Cuts FY22 Outlook
Bausch Health Companies Inc (NYSE: BHC) has reported Q1 revenues of $1.92 billion, down 5% Y/Y. Excluding the unfavorable impact of foreign exchange of $41 million and... 
Via Benzinga

Performance

YTD
-65.53%
-65.53%
1 Month
-55.40%
-55.40%
3 Month
-58.18%
-58.18%
6 Month
-63.31%
-63.31%
1 Year
-69.35%
-69.35%

More News

Read More
77 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Bausch Health Crashes On Unexpected Loss As Bausch & Lomb Starts Trading
Via Investor's Business Daily
103 Biggest Movers From Yesterday
Via Benzinga
Bausch Health Companies: Q1 Earnings Insights
Via Benzinga
Closely Watched Bausch + Lomb IPO Priced Below Expectations
Via Benzinga
Why Is GoodRx (GDRX) Stock Down Today?
Via InvestorPlace
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
Via InvestorPlace
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow
Via Benzinga
Earnings Preview: Bausch Health Companies
Via Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Via Benzinga
Opening Day: Bausch + Lomb Pops In Public Debut
Via Talk Markets
BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today
Via InvestorPlace
Morning Brief: Top Financial Stories Dominating on Friday, May 6
Via Benzinga
Why Cramer Recommends Buying Marvell Technology
Via Benzinga
BLCO Stock IPO: When Does Bausch + Lomb Go Public? What Is the Bausch + Lomb IPO Price Range?
Via InvestorPlace
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Opening Day: Tenon Medical Shares Soar In Market Debut
Via Talk Markets
Jim Cramer Says This Stock Is Still Terrific
Via Benzinga
IPO Market Stalls With Potential Blockbuster Deals Waiting For Rebound
Via Investor's Business Daily
Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO
Via Talk Markets
Opening Day: Cannabis Name Akanda Opens Way Above IPO Pricing, Pulls Back
Via Talk Markets
Opening Day: New Stock Offerings Slump To Lowest Number In A Decade
Via Talk Markets
Bausch Health Companies Q4 Sales, FY22 Outlook Lag Wall Street View
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.